Mannion B - Search Results

1

Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.

Treon SP, Hunter ZR, Matous J, Joyce RM, Mannion B, Advani R, Cook D, Songer J, Hill J, Kaden BR, Sharon D, Steiss R, Leleu X, Branagan AR, Badros A. Treon SP, et al. Among authors: mannion b. Clin Cancer Res. 2007 Jun 1;13(11):3320-5. doi: 10.1158/1078-0432.CCR-06-2511. Clin Cancer Res. 2007. PMID: 17545538 Clinical Trial.

2

Association of TM4SF proteins with integrins: relevance to cancer.

Hemler ME, Mannion BA, Berditchevski F. Hemler ME, et al. Among authors: mannion ba. Biochim Biophys Acta. 1996 Jun 7;1287(2-3):67-71. doi: 10.1016/0304-419x(96)00007-8. Biochim Biophys Acta. 1996. PMID: 8672529 Review. No abstract available.

3

Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29).

Mannion BA, Berditchevski F, Kraeft SK, Chen LB, Hemler ME. Mannion BA, et al. J Immunol. 1996 Sep 1;157(5):2039-47. J Immunol. 1996. PMID: 8757325

4

Beta1 integrins show specific association with CD98 protein in low density membranes.

Kolesnikova TV, Mannion BA, Berditchevski F, Hemler ME. Kolesnikova TV, et al. Among authors: mannion ba. BMC Biochem. 2001;2:10. doi: 10.1186/1471-2091-2-10. Epub 2001 Oct 15. BMC Biochem. 2001. PMID: 11696247 Free PMC article.

5

The light chain of CD98 is identified as E16/TA1 protein.

Mannion BA, Kolesnikova TV, Lin SH, Wang S, Thompson NL, Hemler ME. Mannion BA, et al. J Biol Chem. 1998 Dec 11;273(50):33127-9. doi: 10.1074/jbc.273.50.33127. J Biol Chem. 1998. PMID: 9837878 Free article.

6

A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.

Ooi CE, Weiss J, Elsbach P, Frangione B, Mannion B. Ooi CE, et al. Among authors: mannion b. J Biol Chem. 1987 Nov 5;262(31):14891-4. J Biol Chem. 1987. PMID: 3667613 Free article.

7

Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles.

in't Veld G, Mannion B, Weiss J, Elsbach P. in't Veld G, et al. Among authors: mannion b. Infect Immun. 1988 May;56(5):1203-8. doi: 10.1128/iai.56.5.1203-1208.1988. Infect Immun. 1988. PMID: 3281903 Free PMC article.

8

Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.

Mannion BA, Weiss J, Elsbach P. Mannion BA, et al. J Clin Invest. 1990 Mar;85(3):853-60. doi: 10.1172/JCI114512. J Clin Invest. 1990. PMID: 2179269 Free PMC article.

9

Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.

Mannion BA, Weiss J, Elsbach P. Mannion BA, et al. J Clin Invest. 1990 Aug;86(2):631-41. doi: 10.1172/JCI114755. J Clin Invest. 1990. PMID: 2200807 Free PMC article.

10

Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.

Mannion BA, Kalatzis ES, Weiss J, Elsbach P. Mannion BA, et al. J Immunol. 1989 Apr 15;142(8):2807-12. J Immunol. 1989. PMID: 2539411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters